Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 233	$ 21,100	$ 30,603
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	3,546	2,738	2,427
Share based compensation	6,617	4,549	3,307
Deferred income taxes	(1,564)	(345)	311
Bad debt expense	214	165	130
(Increase) decrease in operating assets and increase (decrease) in liabilities:
Accounts receivable	(41)	509	1,126
Inventories - finished goods	13,432	1,965	(16,536)
Prepaid income taxes	(1,202)	278	(959)
Prepaid expenses and other current assets	147	(363)	(974)
Accounts payable	(2,292)	(12,048)	19,890
Accrued expenses and other current liabilities	8,713	(50)	1,221
Income taxes payable	0	0	(471)
Net cash provided by operating activities	27,803	18,498	40,075
Cash flows from investing activities:
Purchase of minority interest investment in Vetster	(5,000)	0	0
Purchases of property and equipment	(5,260)	(1,752)	(2,432)
Net cash used in investing activities	(10,260)	(1,752)	(2,432)
Cash flows from financing activities:
Dividends paid	(24,537)	(24,384)	(22,687)
Net cash used in financing activities	(24,537)	(24,384)	(22,687)
Net (decrease) increase in cash and cash equivalents	(6,994)	(7,638)	14,956
Cash and cash equivalents, at beginning of year	111,080	118,718	103,762
Cash and cash equivalents, at end of year	104,086	111,080	118,718
Supplemental disclosure of cash flow information:
Cash paid for income taxes	4,312	6,085	10,018
Dividends payable in accrued expenses	$ 1,262	$ 558	$ 198